InnovAge Holding Corp. (INNV)

In January 2026, InnovAge provided an investor presentation in connection with a live webcast investor conference. In December 2025, the company announced its participation in the 44th Annual J.P. Morgan Healthcare Conference. In November 2025, InnovAge and Tampa General Hospital celebrated a partnership for senior care, aiming to expand access to PACE services in the Tampa Bay Area. The company also announced its financial results for the fiscal first quarter ended September 30, 2025, reporting a 15.1% year-over-year revenue increase and a net income of $7.7 million, leading to a stock price increase. Additionally, InnovAge appointed Dr. Paul Taheri as its Chief Medical Officer. In October 2025, InnovAge announced its plan to release fiscal first quarter 2026 financial results and host a conference call. In September 2025, InnovAge appointed Meredith Delk as Executive Vice President and Chief Administrative Officer, increased its share repurchase program by $2.5 million, and reaffirmed its fiscal year 2025 guidance.

InnovAge experiences seasonal variations in enrollment patterns, particularly during the Medicare annual enrollment period in its second fiscal quarter, and anticipates slightly slower growth during the seasonally slower third quarter. Despite these seasonal headwinds, InnovAge reported modest sequential growth in Q3 FY2025. There is a rising demand for care models that allow seniors to remain at home, with PACE being recognized as a high-value solution for individuals with complex needs. The company has, however, faced some bottlenecks in enrollment processing, often related to completing level of care assessments.

InnovAge Holding Corp. operates a healthcare delivery platform specializing in the Program of All-Inclusive Care for the Elderly (PACE), providing patient-centered care to enable frail, dual-eligible seniors to live independently. The company's PACE model integrates medical care, social services, and long-term care, including in-home assessments, medical services, therapy, medication management, transportation, and adult day health centers.

InnovAge Holding Corp. serves participants across multiple states in the United States. Its PACE centers are located in California, Colorado, Florida, New Mexico, Pennsylvania, and Virginia. The company's corporate headquarters is situated in Denver, Colorado.

InnovAge's brand reputation has been influenced by regulatory actions and subsequent operational changes. Sanctions in Colorado were lifted in May 2024, following Sacramento in November 2023, allowing the company to resume enrollment. In October 2023, a report from The Capitol Forum alleged that InnovAge significantly reduced staff in its compliance, quality, and nursing departments, raising concerns about patient harm and regulatory compliance.

InnovAge Holding Corp.'s ownership is primarily concentrated among institutional investors, holding 95.03% of the shares. Apax Partners (UK) Ltd. is the largest shareholder, owning 83.54% of the company's shares. Other notable institutional investors include T. Rowe Price Investment Management, Inc., Coliseum Capital Management, LLC, BlackRock, Inc., and Vanguard Group Inc. Individual ownership accounts for 1.62%, while insiders hold 1.00% of the stock.